Q Chip Appoints Jeremy Curnock Cook as Non-Executive Director.

Wednesday 1st of June 2005 8:00

Q Chip Appoints Jeremy Curnock Cook as Non-Executive Director.

Cardiff, Wales, United Kingdom, 20 June 2005. Q Chip, the drug delivery company offering controlled release systems to the pharmaceutical industry, is pleased to announce the appointment of Jeremy Curnock Cook as a Non-Executive Director. He will bring extensive commercial, technical and governance experience to the Board of Q Chip.

Jeremy Curnock Cook is currently Executive Chairman of Bioscience Managers Ltd, which he founded in 2001. Prior to this he created and led the Rothschild Bioscience Unit, the international and multidisciplinary team managing a number of funds aimed at early and mid-stage focussed investments. Under Jeremy Curnock Cook’s leadership the Unit was highly successful in generating significant value and returns.

He currently holds directorships in a number of life-science companies, including Chairman of Targeted Genetics Inc. (USA) and atugen AG (Germany), and director of Inflazyme Pharmaceuticals (Canada) and Sirna Therapeutics (USA).

Mr Curnock Cook joins Q Chip as the company scales up its MicroPlant technology, widening the capability to develop sophisticated drug delivery solutions for a range of therapeutic applications.

Commenting upon his appointment Mr Curnock Cook said “I am thrilled to have the opportunity to work with Q Chip at this exciting stage in its growth. Its unique bio-encapsulation technology has applications in a range of therapeutic areas such as biopharmaceuticals, small molecules and cell therapies, where controlled and sustained drug delivery offers greater effectiveness and safety profiles. Q Chip’s platform is capable of removing a layer of technical barriers that have prevented a whole segment of the biotechnology industry from realising the full-value of their investments.”

Q Chip’s scaleable bio-encapsulation technology enables the development and production of a range of therapeutic applications in commercial volumes. Through a unique and sophisticated encapsulation process the MicroPlant platform enables biotechnology companies to take their products through clinical trials and the next stage of commercial deployment.

Q Chip’s Chief Executive Mark Barry said “We are delighted to have attracted a director of the calibre and reputation of Jeremy Curnock Cook. His global expertise in the biotechnology industry and business and investment acumen will be of immense value to the Company. His guidance and expertise is exactly what Q Chip needs to achieve its long term business goals.”

About Q Chip Ltd
Q Chip is a privately held drug delivery company specialising in smart release systems, based upon its MicroPlant platform. MicroPlant, which meets GMP standards, is scaleable and addresses the issues associated with existing micro-encapsulation technologies. Q Chip is headquartered at the Cardiff Medicentre. It was founded in 2003 by Mark Barry and Dr Jo Daniels. For more information www.q-chip.com

More About Jeremy Curnock Cook
Mr. Cook founded the International Biochemicals Group in 1975, which was sold to Royal Dutch Shell in 1985, serving as managing director until 1987. From 1987 to 2000, he was a director of Rothschild Asset Management Limited and was responsible for the Rothschild Bioscience Unit. Mr Curnock Cook has served on the Boards of more than 30 companies in the life science sector based in North America, Europe, Japan and Australia. He holds an M.A. in Natural Sciences from Trinity College, Dublin.

Q Chip will be attending BIO 2005, the annual gathering of all key figures in the global biotechnology industry, which takes place in Philadelphia, USA between June 19 and 22. Attendees are invited to find out more about Q Chip by visiting it at the UK Pavilion, Booth # 2461.

FOR MORE INFORMATION.
Corporate:                                     Media and Public Relations:
Mark Barry,                                   Richard Hayhurst
CEO,                                            Senior Adviser
Q Chip Ltd.                                    Alto Marketing Ltd
Tel No; + 44 (0) 29 2068 2092         Tel No; +44 (0) 1489 557672
Email: mark.barry@q-chip.com      + 44 (0) 777 821527
                                                    richardh@alto-marketing.com
 

Related Web-Links

Download PDF